Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Orchestra BioMed Holdings (OBIO) Other Gross PP&E Adjustments (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 216.78% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 216.78% year-over-year, with the annual reading at $1.8 million for FY2025, 216.78% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $1.8 million at Orchestra BioMed Holdings, up from $1.5 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $1.8 million in Q4 2025, with the low at -$1.5 million in Q1 2023.
  • Average Other Gross PP&E Adjustments over 4 years is $659538.5, with a median of $768000.0 recorded in 2023.
  • The sharpest move saw Other Gross PP&E Adjustments surged 370.42% in 2023, then fell 23.96% in 2024.
  • Over 4 years, Other Gross PP&E Adjustments stood at -$284000.0 in 2022, then soared by 370.42% to $768000.0 in 2023, then dropped by 23.96% to $584000.0 in 2024, then soared by 216.78% to $1.8 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $1.8 million, $1.5 million, and $1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.